Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 101(32): 11658-63, 2004 Aug 10.
Article in English | MEDLINE | ID: mdl-15289610

ABSTRACT

Spatio-temporal studies on the growth of capillary blood vessels and capillary lymphatic vessels in tissue remodeling have suggested that lymphangiogenesis is angiogenesis-dependent. We revisited this concept by using fibroblast growth factor 2 (FGF-2) (80 ng) to stimulate the growth of both vessel types in the mouse cornea. When we lowered the dose of FGF-2 in the cornea 6.4-fold (12.5 ng), the primary response was lymphangiogenic. Further investigation revealed that vascular endothelial growth factor-C and -D are required for this apparent lymphangiogenic property of FGF-2, and when the small amount of accompanying angiogenesis was completely suppressed, lymphangiogenesis remained unaffected. Our findings demonstrate that there is a dose-dependent response of FGF-2 for lymphangiogenesis, and lymphangiogenesis can occur in the absence of a preexisting or developing vascular bed, i.e., in the absence of angiogenesis, in the mouse cornea.


Subject(s)
Fibroblast Growth Factor 2/pharmacology , Lymphangiogenesis/drug effects , Animals , Cell Division/drug effects , Cell Movement/drug effects , Cornea/blood supply , Cornea/physiology , Corneal Neovascularization , Dose-Response Relationship, Drug , Endothelial Cells/cytology , Endothelial Cells/drug effects , Male , Mice , Mice, Inbred Strains , Neovascularization, Physiologic/drug effects , Vascular Endothelial Growth Factor C/pharmacology , Vascular Endothelial Growth Factor D/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...